期刊文献+

拉莫三嗪片致重症多形性红斑1例分析 被引量:1

One Case of Lamotrigine-induced Severe Erythema Multiforme Drug Eruption
下载PDF
导出
摘要 目的探讨拉莫三嗪致重症多形性红斑的处置措施。方法分析1例拉莫三嗪致重症多形性红斑的诊疗经过,结合文献检索,探讨拉莫三嗪致重症多形性红斑的机制和应对措施。结果患者服用拉莫三嗪第55天诊断为重症多形性红斑,立即停用并静脉滴注甲泼尼龙琥珀酸钠等相关治疗,患者病情逐步好转。停药第19天,患者皮疹明显好转,瘙痒感消失。结论拉莫三嗪致重症多形性红斑应立即停药,给予糖皮质激素等对症治疗。 Objective To explore ways to treat Stevens Johnson syndrome induced by lamotrigine.Methods The diagnosis and treatment of one case of Stevens Johnson syndrome induced by lamotrigine was analyzed.The mechanism by which lamotrigine induced Stevens Johnson syndrome was discussed in combination with literature.Results The patient was diagnosed with Stevens Johnson syndrome on the 55th day he took lamotrigine.The drug was stopped immediately.His condition gradually improved after the treatment with intravenous methylprednisolone sodium succinate.Skin rash was significantly improved,and itching disappeared on the 19th day of withdrawal.Conclusion The use of lamotrigine should be stopped immediately should Stevens Johnson syndrome occur.Glucocorticoid and other drugs should be given as symptomatic treatment.
作者 王晓 吴玲娣 王军 魏伟 王维波 王海英 WANG Xiao;WU Lingdi;WANG Jun;WEI Wei;WANG Weibo;WANG Haiying(Sheng li Oilfield Central Hospital,Dongying Shandong 257034,China;Shandong Center for Food and Drug Evaluation&Certification,Jinan Shandong 250041,China;Inspection Center for Food and Drug,Dongying Shandong 257091,China;Dongying People's Hospital,Dongying Shandong 257091,China)
出处 《中国药物警戒》 2020年第11期835-837,共3页 Chinese Journal of Pharmacovigilance
关键词 拉莫三嗪 重症多形性红斑 不良反应 lamotrigine Stevens Johnson syndrome adverse reactions
  • 相关文献

参考文献2

二级参考文献28

  • 1Roujeau J C. Stern R S.Severe adverse cutaneous reactions to drugs[J]. N Engl J Me, d, 1994,331 (19):1272-1285.
  • 2Chung W H, Hung S I, Hong H S, et al. Medical genetics: a marker for Stevens-Johnson syndrome[J]. Nature, 2004,428(6982):486.
  • 3Hung S I, Chung W H, Jee S H, et al. Genetic susceptibility to carbamazepine induced cutaneous adverse drug reactions[J].Pharmacogenet Genomics, 2006,16 (4) :297-306.
  • 4Miller J W. Of race, ethnicity and rash: the genetics of antiepileptic drug-induced skinreactions[J].Epilepsy Curr, 2008,8(5): 120-121.
  • 5Wu X T, Hu F Y, An D M, et al.Association between carbamazepine-induced cutaneous adverse drug reactions and the HLA-B*1502 allele among patients in central China[J]. Epilepsy Behav, 2010,19(3):405-408.
  • 6An D M, Wu X T, Hu F Y, et al. Association study of lamotrigineinduced cutaneous adverse reactions and HLA-B* 1502 in a Han Chinese population[J].Epilepsy Res, 2010,92(2-3):226-230.
  • 7Locharemkul C, Loplumlert J, Limotai C, et al. Carbamazepine and phenytoin induced Stevens-Johnson syndrome is associated withHLA-B* 1502 allele in Thai population [J].Epilepsia, 2008,49 (12):2087-2091.
  • 8Tassaneeyakul W, Tiamkao S, Jantararoungtong T, et al. Association between HLA-B*1502 and eous adversedrug reactions 2010, 51 (5):926-930. severe cutanin a Thai population [J].Epilepsia.
  • 9Mehta T Y, Prajapati L M, Mittal B,et al. Association of HLA- B*1502 allele and carbamazepine-induced Stevens-Johnsonsyndrome among Indians[J]. Indian J Dermatol Venereol Leprol2009,75 (6):579-582.
  • 10Kaniwa N, Saito Y, Aihara M,et al.HLA-B locus in Japanese patientswithanti-epileptics andallopurinol-relatedStevens-Johnson syndrome and toxic epidermal necrolysis [J].Pharmacogenomics, 2008,9(11):1617-1622.

共引文献12

同被引文献8

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部